Comparative genomic classification of human hepatocellular carcinoma;Az emberi májrák komparatív genomikai osztályozása

Magyar Onkologia

Volumn 53, Issue 1, 2009, Pages 61-67

  Pál, Kaposi Novák ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

DNA microarray; Genomic classification; Hepatocellular carcinoma; Liver; Transgenic mice

Indexed keywords

COMPLEMENTARY DNA; PARAFFIN; SCATTER FACTOR RECEPTOR; TRANSCRIPTOME; TRANSFORMING GROWTH FACTOR ALPHA; CLAUDIN 4; CLDN7 PROTEIN, HUMAN; MEMBRANE PROTEIN; MYC PROTEIN; MYC PROTEIN, MOUSE; TUMOR MARKER;

AMPLICON; ANIMAL TISSUE; ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DNA TEMPLATE; GENE AMPLIFICATION; GENE EXPRESSION PROFILING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL; LIVER CELL CARCINOMA; LIVER TUMOR; MICROARRAY ANALYSIS; MORPHOLOGY; MOUSE; NONHUMAN; ONCOGENE MYC; REPRODUCIBILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ANIMAL; CANCER DIAGNOSIS; CLASSIFICATION; COMPARATIVE STUDY; GENETICS; GENOMICS; METHODOLOGY; MICRODISSECTION; PROGNOSIS; PROTEOMICS; RETROSPECTIVE STUDY;

ANIMALS; CARCINOMA, HEPATOCELLULAR; EARLY DETECTION OF CANCER; GENOMICS; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; MEMBRANE PROTEINS; MICE; MICROARRAY ANALYSIS; MICRODISSECTION; PROGNOSIS; PROTEOMICS; PROTO-ONCOGENE PROTEINS C-MET; PROTO-ONCOGENE PROTEINS C-MYC; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION, GENETIC; TRANSFORMING GROWTH FACTOR ALPHA; TUMOR MARKERS, BIOLOGICAL;

EID: 67649882024     PISSN: 00250244     EISSN: None     Source Type: Journal    
DOI: 10.1556/MOnkol.53.2009.1.9     Document Type: Article

References (11)

1. Kaposi-Novak P, Lee JS, Gomez-Quiroz L, et al. Met-regulated expression signature defines a subset of human hepatocellular carcinomas with poor prognosis and aggressive phenotype. J Clin Invest 116:1582-1595,2006
2. Kaposi-Novak P, Lee JS, Mikaelyan A, et al. Oligonucleotide micro-array analysis of aminoallyl-labeled cDNA targets from linear RNA amplification. Biotechniques 37:580,582-586,588, 2004
3. Paska C, Bogi K, Szilak L, Kaposi-Novak P, et al. Effect of formalin, acetone, and RNAlater fixatives on tissue preservation and different size amplicons by real-time PCR from paraffin-embedded tissue. Diagn Mol Pathol 13:234-240,2004
4. Lotz G, Kiss A, Kaposi-Novak P, et al. Hepatitis viruses and hepa-tocarcinogenesis. J Physiol Paris 95:417-422, 2001
5. Szabo E, Paska C, Kaposi-Novak P, et al. Similarities and differences in hepatitis B and C virus induced hepatocarcinogenesis. Pathol Oncol Res 10:5-11, 2004
6. Kiss A, Lotz G, Kaposi-Novak P, Schaff Z. Hepatitis viruses and hepatocarcinogenesis. Orvosi Hetilap 143:83-86, 2002
7. Glasz T, Hortovanyi E, Mozes G, et al. Chlamydia pneumoniae in coronary bypass grafts of redo patients. The concept of the 'adven-titial baseline infection'. Pathol Res Pract 200:609-618,2004
8. Podanyi B, Kiss A, Kaposi-Novak P, et al. Hepatitis C virus RNA in the cutaneous eruption but not in the symptom-free skin from patient with prurigo simplex and chronic C hepatitis. J Eur Acad Dermatol Venereol 19:520-522, 2005
9. Podanyi B, Kiss A, Kaposi-Novak P, et al. Hepatitis C virus RNA in the skin eruption from patients with prurigo and chronic hepatitis C. Orvosi Hetilap 145:2371-2374, 2004
10. Tokes AM, Kulka J, Paku S, et al. Claudin-1, -3 and -4 proteins and mRNA expression in benign and malignant breast lesions: a research study. Breast Cancer Res 7:R296-R305,2005
11. Kulka J, Tokes AM, Kaposi-Novak P, et al. Detection of HER-2/neu gene amplification in breast carcinomas using quantitative realtime PCR - a comparison with immunohistochemical and FISH results. Pathol Oncol Res 12:197-204,2006